Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for OpGen, Inc. (OPGN : NSDQ)
 
 • Company Description   
OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland.

Number of Employees: 99

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.38 Daily Weekly Monthly
20 Day Moving Average: 504,703 shares
Shares Outstanding: 46.56 (millions)
Market Capitalization: $17.58 (millions)
Beta: -0.50
52 Week High: $3.72
52 Week Low: $0.31
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -29.44% -25.80%
12 Week -53.40% -48.62%
Year To Date -62.25% -54.78%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9717 KEY WEST AVENUE SUITE 100
-
ROCKVILLE,MD 20850
USA
ph: 240-813-1260
fax: 301-869-9684
investorrelations@opgen.com http://www.opgen.com
 
 • General Corporate Information   
Officers
Oliver Schacht - Chief Executive Officer
Albert Weber - Chief Financial Officer
Mario Crovetto - Director
R. Donald Elsey - Director
Prabha Fernandes - Director

Peer Information
OpGen, Inc. (CHCR)
OpGen, Inc. (ESRX)
OpGen, Inc. (MYDP)
OpGen, Inc. (GBCS)
OpGen, Inc. (LAXAF)
OpGen, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 68373L307
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 46.56
Most Recent Split Date: 8.00 (0.05:1)
Beta: -0.50
Market Capitalization: $17.58 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.15 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.54 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.51
Price/Cash Flow: -
Price / Sales: 4.45
EPS Growth
vs. Year Ago Period: 48.28%
vs. Previous Quarter: 57.14%
Sales Growth
vs. Year Ago Period: -43.37%
vs. Previous Quarter: -67.04%
ROE
03/31/22 - -72.67
12/31/21 - -71.61
09/30/21 - -82.94
ROA
03/31/22 - -40.43
12/31/21 - -41.33
09/30/21 - -45.49
Current Ratio
03/31/22 - 1.76
12/31/21 - 2.00
09/30/21 - 1.55
Quick Ratio
03/31/22 - 1.69
12/31/21 - 1.93
09/30/21 - 1.48
Operating Margin
03/31/22 - -683.15
12/31/21 - -666.22
09/30/21 - -687.05
Net Margin
03/31/22 - -680.36
12/31/21 - -810.33
09/30/21 - -829.32
Pre-Tax Margin
03/31/22 - -676.84
12/31/21 - -807.29
09/30/21 - -826.17
Book Value
03/31/22 - 0.73
12/31/21 - 1.06
09/30/21 - 0.87
Inventory Turnover
03/31/22 - 1.90
12/31/21 - 2.13
09/30/21 - 2.11
Debt-to-Equity
03/31/22 - 0.23
12/31/21 - 0.17
09/30/21 - 0.19
Debt-to-Capital
03/31/22 - 18.89
12/31/21 - 14.84
09/30/21 - 16.32
 

Powered by Zacks Investment Research ©